Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Pharma Industry Analysis

UpdatedJul 28, 2026
DataAggregated Company Financials
Companies2
  • 7D4.0%
  • 3M-8.2%
  • 1Y-15.7%
  • YTD-7.7%

Over the last 7 days, the Pharma industry has dropped 3.9%, driven by Hypera declining 5.6%. Overall the industry is down 20% in 12 months. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Brazilian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 28 Jul 2026R$16.3bR$9.9bR$1.9b7.4x8.5x1.6x
Thu, 25 Jun 2026R$16.2bR$9.9bR$1.9b7.4x8.4x1.6x
Sat, 23 May 2026R$17.5bR$9.0bR$1.4b10x12.2x1.9x
Mon, 20 Apr 2026R$16.5bR$8.9bR$1.4b10x11.6x1.9x
Wed, 18 Mar 2026R$15.3bR$8.2bR$1.0b11.8x14.6x1.9x
Fri, 13 Feb 2026R$16.3bR$8.1bR$969.3m13.5x16.8x2x
Sun, 11 Jan 2026R$16.2bR$8.1bR$969.3m13.4x16.7x2x
Tue, 09 Dec 2025R$17.3bR$8.1bR$969.3m14x17.9x2.1x
Thu, 06 Nov 2025R$17.2bR$8.1bR$956.2m14.2x18x2.1x
Sat, 04 Oct 2025R$15.5bR$7.7bR$876.7m14.1x17.7x2x
Mon, 01 Sep 2025R$16.6bR$7.7bR$876.7m14.8x18.9x2.1x
Wed, 30 Jul 2025R$17.4bR$7.7bR$934.1m14.7x18.7x2.3x
Fri, 27 Jun 2025R$18.6bR$7.7bR$934.1m15.9x19.9x2.4x
Sun, 25 May 2025R$16.8bR$7.7bR$934.1m14.8x17.9x2.2x
Tue, 22 Apr 2025R$13.9bR$8.5bR$1.5b9.3x9.4x1.6x
Thu, 20 Mar 2025R$13.8bR$8.8bR$1.7b8.1x8.1x1.6x
Sat, 15 Feb 2025R$13.2bR$8.7bR$1.7b9.5x8x1.5x
Mon, 13 Jan 2025R$12.2bR$8.7bR$1.7b8.4x7.3x1.4x
Wed, 11 Dec 2024R$13.1bR$8.7bR$1.7b10x7.9x1.5x
Fri, 08 Nov 2024R$15.1bR$8.9bR$1.7b15.1x8.7x1.7x
Sun, 06 Oct 2024R$18.0bR$8.9bR$1.7b15.2x10.3x2x
Tue, 03 Sep 2024R$19.0bR$8.9bR$1.7b16.5x10.9x2.1x
Thu, 01 Aug 2024R$19.3bR$9.0bR$1.7b10.8x11.7x2.2x
Sat, 29 Jun 2024R$19.2bR$9.0bR$1.7b10.7x11.5x2.1x
Mon, 27 May 2024R$19.9bR$9.0bR$1.7b11.1x12x2.2x
Wed, 24 Apr 2024R$19.6bR$8.9bR$1.6b11.2x12.2x2.2x
Fri, 22 Mar 2024R$23.4bR$8.9bR$1.6b13.4x14.6x2.6x
Sun, 18 Feb 2024R$22.1bR$9.2bR$1.7b11.9x12.7x2.4x
Tue, 16 Jan 2024R$23.1bR$9.2bR$1.7b12.3x13.2x2.5x
Thu, 14 Dec 2023R$23.6bR$9.2bR$1.7b13x13.5x2.6x
Sat, 11 Nov 2023R$21.6bR$9.1bR$1.8b38.2x12.3x2.4x
Mon, 09 Oct 2023R$23.4bR$9.1bR$1.8b39.7x13.3x2.6x
Wed, 06 Sep 2023R$26.2bR$9.1bR$1.8b42.7x14.9x2.9x
Fri, 04 Aug 2023R$29.2bR$9.1bR$1.9b14.1x15.7x3.2x
Price to Earnings Ratio

15.7x


Total Market Cap: R$29.2bTotal Earnings: R$1.9bTotal Revenue: R$9.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Pharma Industry Price to Earnings3Y Average 13.2x202420252026
Current Industry PE
    There are only 2 companies in the Brazilian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 3.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare industry?

BR Market0.74%
Healthcare-0.15%
Pharma4.04%
Pharma4.04%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HYPE3 HyperaR$21.064.1%
+R$576.9m		-18.4%PE8.8x
OFSA3 Ouro Fino Saúde Animal ParticipaçõesR$26.993.9%
+R$54.8m		27.3%PE6x

Latest News

OFSA3
R$26.99
Ouro Fino Saúde Animal Participações
7D
3.9%
1Y
27.3%
HYPE3
R$21.06
Hypera
7D
4.1%
1Y
-18.4%
Narrative Update • Jun 26

HYPE3: Stricter Working Capital And Margin Tailwinds Will Support Future Upside

Hypera's analyst fair value estimate has shifted from R$22.00 to R$25.00 as analysts factor in stricter working capital conditions, gross margin tailwinds, and a higher assumed future P/E multiple supported by the recent upgrade in Street research. What's in the News for Hypera Board meeting scheduled for Jun 23, 2026, at 17:00 UTC to consider, in accordance with the company bylaws, the distribution of interest on equity of R$0.26304 per ordinary share and any other matters on the agenda.